Zhikang is an Intellectual Property Strategist with IPOS International and has led significant projects across diverse industries such as advanced manufacturing, biomedical, healthcare and green technology.
Zhikang has advised a variety of companies from small to medium enterprises to large local enterprises and public agencies on IP issues at various stages of innovation. He specialises in helping businesses to solidify their business plans, articulate the value of their intangible assets and anchor their most strategic business decisions. He provides clear direction and strategy on IP issues that enable companies to scale up and mitigate risks relating to their intangible assets. While providing businesses with the right IP knowledge, he reviews and structures their IP management policies, rights and frameworks. He works closely with enterprises to create a strong competitive edge by leveraging their intangible assets to reap maximum return.
Prior to joining IPOS International, Zhikang was seconded to the National Research Foundation, where he managed two national-level funding schemes to boost Singapore’s innovation ecosystem through impactful research translation and enterprise capability building. Before this appointment, Zhikang was central in developing IP capability, and patent services and products across ASEAN at IPOS. Representing Singapore, he worked closely with ASEAN IP offices on their first regional patent work-sharing programme to accelerate patent applications online. He established another first in assisting Cambodia to re-register granted Singapore patents in Cambodia.
Prior to IPOS, Zhikang was part of A*STAR’s team in charge of developing and commercialising Artificial Cell Membranes as a drug discovery platform. The project culminated in the successful spinoff of ACM Biolabs, operational since 2013.